Assays, Kits, & Reagents

New AMSBIO product range includes a kit to facilitate rapid and efficient differentiation of human iPS or ES cells into skeletal muscle cells in just seven days

This standard 96-well ELISA based assay is a game changer for evaluating convalescent plasma, antibody therapies and determining the effectiveness of vaccines for COVID-19

The Access Interleukin-6 (IL-6) assay is designed to assist physicians in the identification of severe inflammatory response in COVID-19 patients

AMSBIO announces StemFit® for MSC, an optimized medium for expansion and maintenance of Mesenchymal Stem Cells

ERS Genomics holds an exclusive worldwide license from Dr. Charpentier to the foundational patents covering CRISPR/Cas9

New dye offers researchers improved brightness to resolve rare and low antigen density populations more easily

RiboShield™ RNase Inhibitor is a recombinant protein that blocks the activity of a wide range of ribonucleases to reliably protect RNA from RNase digestion

The combined Total Protein / Albumin Standard Kit and the Total Protein / Albumin Standard Level F, are specifically designed and manufactured for the calibration, and calibration verification, of albumin and total protein assays on a wide number of clinical testing systems

Avacta to make a high performance Affimer research ELISA test available to support global research efforts to combat the coronavirus

ImmunoRank offers a faster, simpler, more cost effective way to identify high titer convalescent plasma for use in both treating covid-19 patients and for creating covid-19 hyperimmune globulins